---
title: "editorial aha prevent equations"
year: 2025
month: 02
journal: "American Family Physician"
volume: "109-110"
issue: "02"
pages: ""
doi: ""
pmid: ""
source: "PDF Extraction"
pdf_available: true
original_pdf: "2025-02-editorial-aha-prevent-equations.pdf"
extracted_date: "2025-08-10"
keywords: []
evidence_level: ""
clinical_significance: ""
---

# editorial aha prevent equations

Editorials


Advancing Risk Prediction for Cardiovascular
Disease:​the AHA PREVENT Equations
Sadiya S. Khan, MD, MSc, and Nilay S. Shah, MD, MPH




T     he assessment of absolute cardiovascular risk is essen-
      tial in guiding the primary prevention of cardiovascu-
lar disease (CVD). In 2023, the American Heart Association
                                                                         US population. The derivation of the PREVENT equations
                                                                         was not limited to any racial or ethnic group. This is different
                                                                         from the derivation sample for the Pooled Cohort Equations,
(AHA) developed the sex-specific equations for Predicting Risk           which serves as the basis for ASCVD calculators that include
of CVD EVENTs (PREVENT) to reflect the contemporary                      race (eg, White, African American). However, the accuracy
burden and patterns of CVD risk (https://​professional.heart.            of the PREVENT equations for individual Asian or Hispanic
org/en/guidelines-and-statements/prevent-calculator).1,2                 subgroups has not been tested, and this should be a priority
   The recognition of the complex interplay of obesity, diabetes,        in the future because of the known heterogeneity of CVD (eg,
and kidney disease, which was recently defined by the AHA as             observed higher risk for CVD among South Asian people).5
cardiovascular-kidney-metabolic syndrome, was the impetus                   Quantifying short- and long-term CVD risk is particularly
for developing the PREVENT equations.3 Unlike the Pooled                 relevant for younger adults;​the PREVENT equations estimate
Cohort Equations that predict risk only for atherosclerotic car-         CVD risk at 10 years (short term) and 30 years (long term).
diovascular disease (ASCVD),4 the PREVENT equations esti-                Because age is a major driver of CVD risk, young adults are at
mate the risk for total CVD, which includes heart failure and            low risk in the short term. However, nearly one-half of adults
ASCVD. The PREVENT equations also have separate models                   who have a low risk over the next 10 years are still at high risk
for predicting ASCVD or heart failure alone. They have several           of having CVD in the next 30 years, which would be missed
advantages, including broader generalizability, longer-term risk         with short-term risk estimation alone.6 The 2019 American
estimates, and more comprehensive inclusion of factors related           College of Cardiology/AHA primary prevention guidelines
to cardiovascular-kidney-metabolic syndrome.                             recommend estimating 30-year ASCVD risk for adults 20 to
   The PREVENT equations were derived from a large, diverse,             59 years of age.7 The PREVENT equations allow for estimating
contemporary sample (1992-2022) that included observational              10-year and 30-year risk beginning at 30 years of age, a decade
cohorts and electronic health record data. Because of this and           before the Pooled Cohort Equations, allowing for earlier and
the broad inclusivity in the data sets used, the PREVENT                 more comprehensive risk estimation in the clinician-patient
equations are more accurate at predicting CVD among diverse              discussion.
populations than the Pooled Cohort Equations, which were                    There is flexibility with the PREVENT equations because
based exclusively on observational cohort data from White and            they offer a base model and enhanced models that can be
Black adults.                                                            personalized for each patient with optional predictors. The
   The PREVENT equations demonstrated excellent discrim-                 PREVENT base model includes kidney function with esti-
ination (overall accuracy) and calibration (how well observed            mated glomerular filtration rate per the 2021 Chronic Kidney
outcomes matched predicted outcomes) in the external vali-               Disease Epidemiology Collaboration equation (which does not
dation sample of more than 3 million adults. Although self-              include race) and statin use. The inclusion of kidney function
identified race was not included as a predictor in the PREVENT           reflects the growing burden of chronic kidney disease, an inde-
models, discrimination and calibration were excellent in each            pendent risk factor for CVD. Given the significant increase in
racial and ethnic group studied;​this reflects that the larger,          statin use, the inclusion of patients who take statins and those
more diverse data sets used are representative of the overall            who do not broadens the PREVENT equations’ generalizability
                                                                         and use. In contrast, because the intent of the Pooled Cohort
                                                                         Equations was to specifically guide initiation of statin therapy,
   SADIYA S. KHAN, MD, MSc, and NILAY S. SHAH, MD,
                                                                         the derivation sample included only individuals not taking
   MPH, Northwestern University Feinberg School of Medi-
                                                                         statin therapy.
   cine, Chicago, Illinois
                                                                            The enhanced PREVENT equations include additional risk
   Author disclosure:​No relevant financial relationships.               factors for personalizing risk (ie, urine albumin-creatinine ratio,
   Address correspondence to Sadiya S. Khan, MD, MSc, at                 A1C, and patient zip code for incorporating social deprivation
   s-khan-1@​northwestern.edu.                                           index as a marker for area-level social determinants of health).
                                                                         The nearly universal availability of patients’ residential zip codes

                Downloaded from the American Family Physician website at www.aafp.org/afp. Copyright © 2025 American Acad-
February 2025 • Volume 111, Number 2                                                                               American Family Physician 113
                emy of Family Physicians. For the private, noncommercial use of one individual user of the website. All other rights
                          reserved. Contact copyrights@aafp.org for copyright questions and/or permission requests.
in electronic health records should enable broad application of                validation of the American Heart Association’s PREVENT equations.
                                                                               Circulation. 2024 ;​14 9(6):​4 30-4 4 9.
the PREVENT model with the social deprivation index and
                                                                             2. Khan SS, Coresh J, Pencina MJ, et al. Novel prediction equations for
better account for the influence of neighborhood-level social
                                                                                absolute risk assessment of total cardiovascular disease incorporating
determinants on CVD risk.                                                       cardiovascular-kidney-metabolic health:​a scientific statement from
   The PREVENT equations represent several major advances                       the American Heart Association. Circulation. 2023;​148(24):​1982-2004.
in accurate and comprehensive risk prediction for CVD. They                  3. Ndumele CE, Rangaswami J, Chow SL, et al. Cardiovascular-kidney-
include predictors and outcomes relevant to the contemporary                    metabolic health:​a presidential advisory from the American Heart
                                                                                Association. Circulation. 2023;​148(20):​1606-1635.
US population with a high cardiovascular-kidney-metabolic
                                                                             4. Goff DC Jr, Lloyd-Jones DM, Bennett G, et al. 2013 ACC/AHA guideline
syndrome burden. The PREVENT models have corrected the                          on the assessment of cardiovascular risk:​a report of the American
nearly twofold overprediction of the Pooled Cohort Equations,                   College of Cardiology/American Heart Association Task Force on
leading to lower risk estimates. We await the development of                    Practice Guidelines. Circulation. 2014;​129(25 suppl 2):​S49-S73.

guidelines that consider the PREVENT equations with action-                  5. Diaz CL, Shah NS, Lloyd-Jones DM, et al. State of the nation’s
                                                                                cardiovascular health and targeting health equity in the United
able thresholds for preventive therapies (eg, statins, those that
                                                                                States:​a narrative review. JAMA Cardiol. 2021;​6(8):​963-970.
intensively lower blood pressure, newer therapies). Like any                 6. Marma AK, Berry JD, Ning H, et al. Distribution of 10-year and
clinical tool, as implementation of this new model is consid-                   lifetime predicted risks for cardiovascular disease in US adults:​
ered, ongoing testing and validation in diverse clinical popu-                  findings from the National Health and Nutrition Examination Survey
lations must be a priority.                                                     2003 to 2006. Circ Cardiovasc Qual Outcomes. 2010;​3(1):​8-14 .
                                                                             7. Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA guideline
REFERENCES                                                                      on the primary prevention of cardiovascular disease:​a report of
                                                                                the American College of Cardiology/American Heart Association
1. Khan SS, Matsushita K, Sang Y, et al.;​Chronic Kidney Disease Prognosis
                                                                                Task Force on Clinical Practice Guidelines. Circulation. 2019;​140(11):​
   Consortium and the American Heart Association Cardiovascular-
                                                                                e596-e646. ■
   Kidney-Metabolic Science Advisory Group. Development and




                                            Your favorite
                                        AFP and FPM content:
                                            Now in audio!
                                           Select content from new issues of American Family
                                             Physician and FPM is now available in an audio
                                           format. Download the AAFP Audio app from your
                                                   app store and start listening today!




                                              Audio narration exclusively underwritten by Guardant Health
